Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Clin Pharm Ther ; 45(2): 379-383, 2020 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-31736110

RESUMO

WHAT IS KNOWN AND OBJECTIVE: The HbA1C marker used in assessing diabetes control quality is not sufficient in diabetes patients with thalassaemia. CASE DESCRIPTION: A male diabetic patient with thalassaemia was hospitalized due to distal neuropathic pain, right toe trophic ulcer, unacceptable five-point glycaemic profile and recommended HbA1C value. After simultaneously initiated insulin therapy and management of ulcer by hyperbaric oxygen, the patient showed improved glycaemic control and ulcer healing, which led to the patient's discharge. WHAT IS NEW AND CONCLUSION: In thalassaemia and haemoglobinopathies, due to discrepancies in the five-point glycaemic profile and HbA1C values, it is necessary to measure HbA1C with a different method or to determine HbA1C and fructosamine simultaneously.


Assuntos
Glicemia/metabolismo , Diabetes Mellitus Tipo 2/fisiopatologia , Hemoglobinas Glicadas/análise , Talassemia beta/fisiopatologia , Idoso , Biomarcadores/análise , Diabetes Mellitus Tipo 2/tratamento farmacológico , Pé Diabético/diagnóstico , Pé Diabético/terapia , Frutosamina/análise , Humanos , Oxigenoterapia Hiperbárica , Hipoglicemiantes/administração & dosagem , Insulina/administração & dosagem , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA